- Overview
- Products
- Negative Pressure Wound Therapy
- Wound Dressings and Compression
- Skin Care
- Surgical
- Vascular Access
- Sterilization Monitoring
- Temperature Management
- Adhesive Securement
- Patient Monitoring
- Respiratory Protection
- Securement and Immobilization
- Prevention
- Pressure Injuries
- Adhesive Skin Damage
- Moisture Associated Skin Damage
- Bloodstream Infections
- Hypothermia
- Tube and Line Dislodgement
- Cross Contamination
- Electrode-Related Alarm Fatigue
- Hand Hygiene
- Treatment
- Pressure Injuries
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Traumatic Wounds
- Surgical Incisions
- Open Abdomen
- Incontinence-Associated Dermatitis
- Edema and Lymphedema
- Oncology Care
- C. difficile infection
- Resources
- Education
- Support
-
Take control with universal decolonizationDOWNLOAD THE SKIN AND NASAL INFOGRAPHIC (PDF, 184 KB)
-
One simple step can help prevent SSIsREQUEST SKIN AND NASAL SAMPLE
Request a sample of 3M™ Skin and Nasal Antiseptic
-
Learn more about using 3M™ Skin and Nasal Antiseptic in your facilityCONNECT WITH A 3M SPECIALIST
Our apologies...
An error has occurred while submitting. Please try again later...
Thank You for interest in 3M™ Skin and Nasal Antiseptic
Your request is being processed. A 3M Representative will contact you shortly. Please allow three weeks for shipping of product samples.
Before you get started, you might find these tools helpful:
How to Use-PDF (PDF, 142 KB)
How to Use-Video
Nasal Antiseptic Efficacy: A Summary of Clinical Evidence (PDF, 546 KB)
More product information
If you have any urgent questions or needs, call us at 800-228-3957.
FOR VERMONT
We received your sample request and are unable to fulfill.
There are restrictions to shipping to Vermont licensed Health Care providers in compliance with state product gift ban and disclosure laws.
To learn more about this product, contact a 3M representative .
Thank You
Your form was submitted successfully!
Our Apologies...
An error has occurred while submitting. Please try again later...
Increase confidence in your nasal decolonization protocol.
-
3M™ Skin and Nasal Antiseptic (Povidone-Iodine Solution 5% w/w [0.5% available iodine] USP) Patient Preoperative Skin Preparation was designed to help reduce the risk of factors that can lead to SSIs. With this product you can make a change that makes a real difference.
The effectiveness of 3M™ Skin and Nasal Antiseptic is backed by data from 10 investigator-initiated clinical studies.
-
Improves patient safety and protocol compliance without antibiotics.²
-
Zero S. aureus infection in per protocol analysis with 3M Skin and Nasal Antiseptic, compared to mupirocin.²
-
Unique film-forming polymer increases persistence.
One simple step can help prevent SSIs.
-
30% of surgical patients are already colonized with S.aureus.³
-
80% of SSIs from S.aureus come from the patient's own nasal flora.⁴⁻⁶
-
A single SSI can cost up to $60k per patient.⁷
-
Providers can take control of preoperative nasal decolonization with 3M™ Skin and Nasal Antiseptic.
Key benefits:
- A simple, one-time application
- Helps reduce bacteria that potentially can cause skin infections
- Reduces skin flora by 99.9% within 10 minutes and maintains reduction for 6 hours*
As part of a comprehensive preoperative protocol, 3M™ Skin and Nasal Antiseptic is an important tool to help reduce SSIs while supporting antibiotic stewardship.²’⁹⁻¹²
*when tested on the groin and abdomen [Reference: I2MS-05-010945]
-
Supporting Antibiotic Stewardship Through Effective Nasal Decolonization.
This white paper provides examples of the clinical evidence and findings on 3M™ Skin and Nasal Antiseptic that demonstrate its efficacy, cost effectiveness and overall performance.
Our Apologies...
An error has occurred while submitting. Please try again later...
-
Evidence-based nasal decolonization supported by data. Lots of data.
3M™ Skin and Nasal Antiseptic is the only nasal antiseptic supported by 10 investigator initiated studies. Download a summary of clinical evidence to learn how 3M™ Skin and Nasal Antiseptic is different from other solutions. Inside these summaries you’ll clearly learn that not all nasal antiseptics are created equally.
Our Apologies...
An error has occurred while submitting. Please try again later...
-
Nasal Antiseptic Sample Request
3M™ Skin and Nasal Antiseptic works with a quick one-time application prior to surgery and easily fits into the preoperative protocol, so compliance is ensured.
-
3M™ Skin and Nasal Antiseptic Product BrochureLearn more about what makes 3M™ Skin and Nasal Antiseptic a great addition to your pre-op protocol for nasal decolonization.
-
3M™ Skin and Nasal Antiseptic Safety and Efficacy BrochureRead and review relevant info about a safety assessment of povidone-iodine and an overview of efficacy data.
-
Facts About Iodine and IodophorsUnderstand the truth about iodine sensitivities.
-
3M™ Skin and Nasal Antiseptic InfographicLearn how to protect every patient, every time.
References
-
1. 3M Study-05-011017.
2. Phillips M, Rosenberg A, Shopsin B, et al. Preventing surgical site infections: A randomized, open-label trial of nasal mup. ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol. 2014;35:826-32
3. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001–2002. J Infect Dis. 2006;193:172-179.
4. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mup. to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871-1877.
5. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, deBaere GAJ, Kluytmans JAJW. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol. 2000;21:319-323.
6. Kluytmans JAJW, Mouton JW, Ijzerman EPF, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis. 1995;171:216-219.
7. Anderson DJ, Kaye KS, Chen LF, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE. 2009;4:e8305.
8. Miller LG, McKinnell JA, Singh R, et al. Reduction of MDRO colonization in nursing home residents with routine use of chlorhexidine bathing and nasal iodophor (Project PROTECT). Presented at IDWeek 2016, New Orleans, LA, October 2016.
9. Bebko SP, Green DM, Awad SS. Effect of a preoperative decontamination protocol on surgical site infections in patients undergoing elective orthopedic surgery with hardware implantation. JAMA Surg.15;150:390-295.
10. Brown L, Shelly M, Greene L, et al. The effect of universal intranasal povidone iodine antisepsis on total joint replacement surgical site infections. Presented at the APIC National Conference, Anaheim, CA, June 2014.
11. Waibel ML. Revisiting process improvement for total joint arthroplasty SSI. Presented at the APIC National Conference, Fort Lauderdale, FL, June 2013.
12. Hogenmiller JR, Hamilton J, Clayman T, et al. Preventing orthopedic total joint replacement SSIs through a comprehensive best practice bundle/checklist. Presented at the APIC National Conference, Baltimore, MD, June 2011.
